Shows
Top of the MorningBulls Break Loose | Yes Bank – SMBC Deal | Worldline Exit from IndiaMarket Roars Back:
Ceasefire & Tariff Pause Spark ₹16 Trillion RallyPeace on the borders and a tariff truce overseas gave Indian markets their best day in over four years. With India-Pakistan tensions cooling and US-China easing trade friction, the Nifty soared 3.8% and Sensex jumped 3.7%, adding ₹16 trillion to investor wealth. IT, banking, and blue-chip stocks led the charge, as FIIs and DIIs poured in over ₹2,600 crore. “We’re in a sweet spot,” said Marcellus’ Saurabh Mukherjea, flagging optimism ahead of earnings and a potential EM bull run in 2025.
Trump’s Drug Price Bombshell Rattles Indian Pharma
Do...2025-05-1307 min
Mint PodcastTop of the Morning : Bulls Break Loose | Yes Bank – SMBC Deal | Worldline Exit from IndiaMarket Roars Back: Ceasefire & Tariff Pause Spark ₹16 Trillion RallyPeace on the borders and a tariff truce overseas gave Indian markets their best day in over four years. With India-Pakistan tensions cooling and US-China easing trade friction, the Nifty soared 3.8% and Sensex jumped 3.7%, adding ₹16 trillion to investor wealth. IT, banking, and blue-chip stocks led the charge, as FIIs and DIIs poured in over ₹2,600 crore. “We’re in a sweet spot,” said Marcellus’ Saurabh Mukherjea, flagging optimism ahead of earnings and a potential EM bull run in 2025.Trump’s Drug Price Bombshell Rattles Indian PharmaDon...2025-05-1307 min
Inside Forbes IndiaSun Pharma's Quiet Architect: Inside Dilip Shanghvi's visionIn the latest episode of Inside Forbes India Podcast, Naini Thaker discusses her deep-dive profile on Dilip Shanghvi, the low-key founder of Sun Pharma, India's largest pharmaceutical company. Starting with just $200, Shanghvi's strategic focus on chronic therapies and high-value acquisitions—most notably Ranbaxy—helped shape Sun Pharma into a global force. The conversation explores how the company weathered challenges, such as price erosion, by doubling down on R&D and pivoting toward complex speciality drugs. It also highlights that Shanghvi's leadership is marked by humility, passion for his work, and a focus on patient care rather than wealth accumulation.2025-04-3014 min
Niti ShastraTrump Tariffs: Impact on Indian Economy & Global TradeNamaskar,Here we bring you the podcast on our article “Trump Tariffs: Impact on Indian Economy & Global Trade”. In the said podcast we discuss how Trump tariffs announced on 2nd April 2025 are impacting Indian economy and various sectors like IT, Pharma, Gems & Jewellery, Agriculture, Electronics Manufacturing, Auto & Textiles. We discuss how the tariffs impact Indian trade and strategic alignments and how it can respond to these tariffs.The podcast goes on to discuss the options Indian government has to diffuse and counter these trade trade tariffs from diplomacy to multi-lateral agreements to state support of vari...2025-04-061h 22
Mint PodcastTop of the Morning : Indian Pharma Dodges U.S. Tariffs | BMW EV Sales Soar in IndiaTo get your dose of daily business news, tune into Mint Top of the Morning on Mint Podcasts available on all audio streaming platforms.This is Nelson John, and I'll bring you the top business and tech stories, let's get started. Trump’s Tariffs Shake Global Trade, But India Stays SteadyDonald Trump’s sweeping new tariffs—10% on all imports and 27% on Indian goods—sent global markets into a tailspin, yet India’s markets showed resilience. While Japan’s Nikkei plunged nearly 3% and Hong Kong’s Hang Seng fell 1.5%, India’s Sensex and Nifty 50 barely f...2025-04-0406 min
Top of the MorningIndian Pharma Dodges U.S. Tariffs | BMW EV Sales Soar in IndiaTo get your dose of daily business news, tune into Mint Top of the Morning on Mint Podcasts available on all audio streaming platforms.https://open.spotify.com/show/7x8Nv1RlOKyMV5IftIJwP1?si=bf5ecbaedd8f4ddcThis is Nelson John, and I'll bring you the top business and tech stories, let's get started. Trump’s Tariffs Shake Global Trade, But India Stays SteadyDonald Trump’s sweeping new tariffs—10% on all imports and 27% on Indian goods—sent global markets into a tailspin, yet India’s m...2025-04-0408 min
Mint PodcastTop of the Morning : DLF’s Record Sales | Meta’s Cable to Boost India | India’s Auto Giants Face U.S. Tariff HitTo get your dose of daily business news, tune into Mint Top of the Morning on Mint Podcasts available on all audio streaming platforms.This is Nelson John, and I'll bring you the top business and tech stories, let's get started. Jubilant FoodWorks Bets Big on Tech & ExpansionJubilant FoodWorks is ramping up its Domino’s India expansion from 2,000 to 3,000 stores, backed by Elate, an in-house Android-based POS system aimed at improving efficiency across its brands (Domino’s, Popeyes, Dunkin’, Hong’s Kitchen). CEO Sameer Khetarpal promises tech upgrades every six months, integrating AI into s...2025-03-2806 min
Top of the MorningMeta’s Undersea Cable to Boost India | Investors Dump US Stocks on Tariff FearsTo get your dose of daily business news, tune into Mint Top of the Morning on Mint Podcasts available on all audio streaming platforms.https://open.spotify.com/show/7x8Nv1RlOKyMV5IftIJwP1?si=bf5ecbaedd8f4ddcThis is Nelson John, and I'll bring you the top business and tech stories, let's get started. Jubilant FoodWorks Bets Big on Tech & ExpansionJubilant FoodWorks is ramping up its Domino’s India expansion from 2,000 to 3,000 stores, backed by Elate, an in-house Android-based POS sys...2025-03-2810 min
Pharma Marketing Playbook: Data, GenAI, and BeyondFrom Medical Rep to Pharma Leader: Alhad Mahajani’s Success Formula!Join Saumya Prakash in this compelling episode of 'Pharma Marketing Playbook' as he interviews the esteemed Alhad Mahajani. Discover Alhad's remarkable career journey from a medical representative to a vice president in pharmaceutical marketing, and gain valuable insights into the growing role of digital channels, patient-centricity, and data-driven strategies in the pharma industry. Alhad also shares his guiding philosophies and experiences as an angel investor, offering practical advice for upcoming leaders and young professionals in the field.00:00 Introduction to the Pharma Marketing Playbook00:30 Guest Introduction: Mr. Alhad Mahajani02:07 Career Journey and Pivotal Experiences2025-03-2139 min
Niti ShastraChina's Rise as a Techno-Industrial Power: The Great Leap ForwardNamaskar,We are bringing you the podcast on China’s Rise as Techno-Industrial power and the Great Leap it has made in various fields aspiring to make China a global power i.e. China Dream 2049. We discuss how the World Bank and Wall Street enabled the rise of China hoping to co-opt it while maintaining its global dominance. From Tech War to EVs to Rare Earth’s to Pharma to Bio-Tech to Artificial Intelligence, China’s rise is now challenging the American built post war order. But is China unstoppable and what consequences it will have o...2025-03-2038 min
Off Script: A Pharma Manufacturing PodcastAxplora expands ADC capacity, Merck KGaA CDMO business slump, FDA issues a warning letter to Granules India [The good, the bad, the ugly]Join us each week as we do a quick review of three compelling stories from the pharma world — one good, one bad, and one ugly. Up this week:
The good — Axplora expands its antibody-drug conjugate (ADC) manufacturing capacity to support growing demand.
The bad — Merck KGaA’s CDMO business reports a decline
The ugly — The FDA issues a warning letter to Granules India over manufacturing violations
2025-03-1703 min
Today in India - Morning News BriefMarch 11th, 2025Headlines from India Today on March 11th, 2025, cover a diverse array of topics. India's cricket team is celebrated for winning the Champions Trophy while captain Rohit Sharma plans to play in the 2027 World Cup. The film "Laapataa Ladies" won big at the IIFA awards, while a potential death penalty for forced religious conversions in Madhya Pradesh is debated. Mukesh Ambani faces trade policy challenges, and Sun Pharma is set to acquire Checkpoint Therapeutics. Additionally, the Khelo India Winter Games saw success for Himachal Pradesh athletes, and Bihar's alcohol prohibition faces scrutiny. **Finally, India's AI sector is projected to create...2025-03-1122 min
Top of the MorningIndia’s Investment Summit Rush: Big Promises, But What’s the Reality?It's Thursday, February 27th, 2025. This is Nelson John, let's get started.India is in a fierce race to attract investments, with at least 10 states holding investor summits in the past three months. Rajasthan leads with ₹35 trillion in MoUs, followed by Odisha at ₹16.73 trillion and Karnataka at ₹10.27 trillion. Even states with weaker industrial bases, like Bihar and Kerala, secured commitments worth ₹1.81 trillion and ₹1.53 trillion, respectively. At the World Economic Forum in Davos, several states pitched for global investments, contributing to India’s reported ₹20 trillion haul. The real challenge? Converting these commitments into actual investments. Even a 50% realizat...2025-02-2711 min
Top of the MorningGlobal private equity firms in the Race for a $3 Billion Deal - Gland PharmaWelcome to Top of the Morning by Mint, your weekday newscast that brings you five major stories from the world of business. It's Thursday, February 13, 2025. This is Nelson John, let's get started. Amid India-China geopolitical tensions, China's Fosun Pharmaceutical is in discussions with three global private equity firms to sell its majority stake in the Hyderabad-based Gland Pharma. Fosun currently owns about 51% of Gland Pharma, after initially acquiring a 74% stake for $1.2 billion. They have hired investment banks Morgan Stanley and UBS to assist with the sale. Global private equity firms Bl...2025-02-1306 min
The Mutual Fund NavigatorNippon India Pharma Fund – A Simplified Guide for Retail InvestorsWelcome to our latest episode, where we simplify the intricacies of investing with a focus on the Nippon India Pharma Fund! If you’re a retail investor intrigued by the pharmaceutical sector but unsure where to start, this guide is crafted just for you.
Join us as we unravel the unique aspects of this fund, exploring its potential benefits and how it can fit into your investment portfolio. We’ll discuss key trends in the pharmaceutical industry and share expert insights that will empower you to make informed decisions. Whether you’re new to investing or looking to div...2025-01-0118 min
DostcastBig Pharma in India EXPOSED: Doing This Will Ruin Your Health | Dostcast w/ Nikkhil K. MasurkarNikkhil K. Masurkar is the CEO of ENTOD Pharmaceuticals, a research-based pharmaceutical company specializing in ophthalmic, ENT, and dermatological medicines. He studied as a research pharmacist at King's College London and is a member of the Royal Pharmaceutical Society in the UK. He has played a key role in creating innovative treatments, such as eye drops to slow down myopia in children and a facial gel to reduce fine lines and wrinkles. He is often referred to as the “Elon Musk of the Indian Pharma Industry” for his groundbreaking innovations in the eye care and skincare segments.
ENTOD website: http...2024-12-031h 18
Pharma Marketing Playbook: Data, GenAI, and BeyondPharma Marketing Decoded: Patient centricity, AI, Data, and BeyondWelcome to an enlightening episode of the Pharma Marketing Playbook! In this episode titled 'Data, Gen-AI and Beyond', host Saumya Prakash, co-founder of Multiplier AI, sits down with the seasoned pharmaceutical marketing leader, Mr. Subhojit Mukherjee. Explore cutting-edge strategies, the impact of emerging technologies, and how data-driven insights are transforming the pharmaceutical landscape. Mr. Mukherjee shares his journey, the role of AI in addressing industry challenges, patient-centric marketing campaigns, and essential leadership lessons. Stay tuned for invaluable insights to stay ahead in the rapidly evolving world of pharma marketing.
Key Highlights:-
00:00 Introduction to the...2024-11-3042 min
Pharma Marketing Playbook: Data, GenAI, and BeyondLeading the Charge: Patient-Centric Healthcare with Data Gen AI in PharmaIn this exciting episode of the Pharma Marketing Playbook: Data, Gen, AI, and Beyond, as she interviews Dr. Crystal Variava, a visionary leader in audiology and the founder of True and Trusted. Tune in to explore Dr. Crystal remarkable career in healthcare, from clinical practice in audiology to strategic leadership and entrepreneurship. Discover her insights on patient-centric communication, the latest advancements in hearing and balance care, and the evolving role of AI and data analytics in pharma marketing. Gain actionable advice for aspiring healthcare professionals and learn how technology is transforming the healthcare landscape.
Key Highlights:- 2024-11-2255 min
Voices of PharmaBeyond Boundaries: Dr. Bhalgat Connects Climate Change and Biopharma in a New Era of Health | #E29-Voices of Pharma | Pharma NowIn an insightful interview with Pharma Now, Dr. Mahesh Bhalgat, Group MD of Veeda Clinical Research, shared his extraordinary journey from studying pharmacy in Mumbai to holding prominent roles in the US and now spearheading one of India’s leading CROs. Dr. Bhalgat discussed the trajectory of his career, his deep commitment to healthcare, and the unique opportunities he's encountered in the fields of vaccines and biopharmaceuticals.
He also connected critical global challenges, like antimicrobial resistance and climate change with vaccine innovation, and spoke passionately about the growing importance of mRNA technology and biologics. Dr...2024-11-1328 min
Voices of PharmaAI, Innovation, and Saving Lives: Dr. Ramesh Matur’s Journey | #E27-Voices of Pharma | Pharma Now
In this fascinating interview, Dr. Ramesh Matur, Head of R&D at Biological E Limited, recounts his inspiring journey from Warangal to leading revolutionary vaccine development projects in India. He highlights the complexities and triumphs of developing the 14-valent pneumococcal conjugate vaccine, a groundbreaking innovation aimed at saving the lives of children under five. Dr. Matur emphasizes the significance of innovation and collaboration in achieving this milestone in vaccine R&D.
He also explores the future of vaccine development in India, with a special focus on the integration of artificial intelligence (AI) and digital...2024-10-2530 min
Voices of PharmaIndia’s mRNA Breakthroughs: Inside the Journey of Gennova Biopharmaceuticals | #E26-Voices of Pharma | Pharma NowIn this insightful interview, Dr. Ajay Singh, Head of the mRNA Division at Gennova Biopharmaceuticals, delves into the groundbreaking advancements of mRNA technology in the pharmaceutical landscape. He narrates the development journey of India’s first mRNA-based COVID-19 vaccine and explains the broader applications of this transformative technology in areas like cell and gene therapy.
Dr. Singh emphasizes the pivotal role mRNA will play in shaping future healthcare innovations, highlighting the potential for faster vaccine development, reduced costs, and enhanced therapeutic interventions.
Follow our website for in-depth articles and industry updates: https://www.pharmanow.live/
Follow our social media handles:2024-10-2415 min
Voices of PharmaThe Future of Digital Transformation in the Pharma Industry, ft. Mr. Manish | #E25-Voices of Pharma | Pharma NowIn this episode of the Pharma Now podcast, we speak with Mr. Manish Manakchand, the Commercial Director for IDBS Asia. Mr. Manakchand discusses the company's role in digital transformation within the pharmaceutical industry.
Mr. Manakchand expresses his optimism for the growth of the pharmaceutical industry in Asia, particularly India, driven by factors like talent availability, cost advantages, and the increasing focus on biosimilars. He envisions a significant role for digital transformation in supporting this growth.
Follow our website for in-depth articles and industry updates: https://www.pharmanow.live/
Follow our social media handles:
Facebook: https://www.facebook.com...2024-10-2312 min
Voices of PharmaClinoxy Solutions: Revolutionizing Pharma Education with Satish Kumar | #E23-Voices of Pharma | Pharma NowIn this episode, we're joined by Mr. Satish Kumar Vemavarapu, the founder of Clinoxy Solutions, a leading provider of skill development training programs for pharmacy professionals in India.
Mr. Vemavarapu shares his inspiring journey from a son of a farmer to a successful entrepreneur in the pharma industry. He talks about the importance of skill development in today's competitive job market and how Clinoxy Solutions is helping pharmacy graduates acquire the necessary skills to succeed in their careers.
Mr. Vemavarapu also discusses the challenges faced by the Indian pharma industry in terms of lack of...2024-10-1513 min
Pharma Marketing Playbook: Data, GenAI, and BeyondInnovate and Lead: Pharma Marketing in the AI Era with Prashant MenonIn this exciting episode of the Pharma Marketing Playbook, Data Gen AI and Beyond, where Saumya Prakash, co-founder at Multiplier AI, hosts Mr. Prashant Menon, a distinguished leader in the pharmaceutical industry. Explore Prashant’s comprehensive journey from field sales to senior management roles across top Indian MNCs like CIPLA and Sun Pharma, and delve into his insights on transitioning through career phases, transforming marketing strategies, and leading organizations. Discover strategic alignments, customer profiling, and the vital role of AI in enhancing pharma marketing dynamics. Gain insights on leveraging technology for superior diagnostics, patient management, and market comprehension. Prashant sh...2024-10-1529 min
Voices of PharmaTech Meets Pharma: Discover how Mr. Tarun is Driving Drug Discovery with AI | #E20-Voices of Pharma | Pharma NowJoin us for an exclusive conversation with Mr. Tarun Walia, Senior Director of Data Science Evaluation and Integration at a leading pharmaceutical company in Boston. In this episode, Tarun shares his remarkable journey from biotechnology engineering in India to becoming a key driver of pharma innovation.
He discusses the transformative role of AI, data science, and M&A strategies in shaping the future of drug discovery and pharmaceutical development. Tarun’s deep expertise offers listeners a behind-the-scenes look at the technologies revolutionizing the industry.
Follow our website fo...2024-09-3012 min
Voices of PharmaNavigating Global Pharma Regulations: Insights from Ms. Pushpavalli Krishnamurthy | #E17-Voices of Pharma | Pharma NowJoin us for an insightful interview with Ms. Pushpavalli Krishnamurthy, the Global Head of Regulatory Affairs at Ingredion Incorporated, as she shares her incredible journey from a small town in India to becoming a global leader in pharma compliance.
In this episode, Ms. Pushpavalli sheds light on the complexities of navigating international regulatory frameworks, ensuring transparent labeling, and maintaining the highest standards of compliance across diverse markets. Whether you're in the industry or simply curious about how the world of pharmaceuticals operates behind the scenes, this episode offers a wealth of knowledge and inspiration.
2024-09-2135 min
Voices of PharmaBuilding a Bridge between Academia and Industry, ft. Dr. Ravi Ananthula | E16-Voices of Pharma | Pharma NowFrom humble beginnings as a son of a farmer, Dr. Ananthula's journey to becoming a leading figure in pharmaceutical innovation is nothing short of extraordinary. His passion for using technology to improve drug discovery and development has led him to create Fara Now, a company that is revolutionizing the industry.
In this episode, Dr. Ananthula shares insights into his career, his experiences in Germany, and his decision to return to India to make a significant impact. Discover how his software is helping pharmaceutical companies save time, reduce costs, and ultimately improve the quality of life for millions...2024-09-1626 min
Voices of PharmaUnderstanding Good Manufacturing Practices and Future Opportunities, ft. Mr. Kamal Dua | #E13-Voices of Pharma | Pharma NowJoin us for an enlightening discussion with Mr. Kamal Dua, Associate Professor at the University of Technology Sydney, as he shares his remarkable journey from India to Australia and his expertise in Good Manufacturing Practices (GMP).
In this episode, Mr. Dua explores the vital role of GMP in ensuring the quality, safety, and efficacy of products across various industries, from pharmaceuticals to food production. He also delves into his innovative approach to preparing future industry leaders through real-world projects and a dynamic curriculum, highlighting the evolving landscape of GMP standards and practices.
Follow our...2024-09-0517 min
Voices of PharmaPioneering New Frontiers in Vaccine Manufacturing, ft. Mr. Ashish Sahai | #E12-Voices of Pharma | Pharma NowJoin us as Mr. Ashish Sahai, a renowned expert in the pharmaceutical industry, shares his unique journey from engineering to becoming a leader in vaccine manufacturing. In this episode, he discusses the challenges and opportunities in scaling vaccine production, the innovative strategies employed by his team, and the future of vaccine technology in India.
Mr. Sahai also emphasizes the importance of adaptability, continuous learning, and collaboration in driving success in the fast-evolving pharma landscape. Tune in for a fascinating conversation about innovation and leadership in healthcare.
Follow our website for in-depth articles and industry updates: https...2024-08-2922 min
Voices of PharmaIndia's Pharma Future, ft. Dr. A Ramkishan | #E11-Voices of Pharma | Pharma NowIn this episode, Dr. A. Ramkishan, a distinguished leader in the Indian pharmaceutical sector, provides an in-depth analysis of India's role in the global vaccine production landscape. He discusses the nation's advancements in vaccine manufacturing, the strategic initiatives driving these developments, and the challenges faced in scaling production to meet global demand.
Dr. Ramkishan also highlights the importance of innovation, government support, and international collaborations in solidifying India’s position as a leader in the pharmaceutical industry.
Follow our website for in-depth articles and industry updates: https://www.pharmanow.live/
Fol...2024-08-2310 min
Har Stock Kuch Kehta HaiMankind PharmaFrom humble beginnings to becoming one of the popular pharmaceutical companies in India, the story of Mankind Pharma is not just about financial success. It is also about relentless determination and innovative strategies in one of the most complex sectors - pharmaceuticals. In this episode, RJ Rohan will take you through the journey of Mankind Pharma, the flagship pharma company of India.2024-08-2006 min
Voices of PharmaDrug discovery, Indian education system, elucidated by Dr. Ranjan Chakrabarti | #E10-Voices of Pharma | Pharma NowIn this engaging podcast episode, Dr. Ranjan Chakrabarti, a prominent figure in India's pharmaceutical industry, shares his expert insights on the current state of drug discovery in India. He explores the innovative strides being made, the significant challenges faced by researchers, and the critical role of collaboration between academia and industry.
Dr. Chakrabarti also discusses the future potential of India's pharma sector, emphasizing the need for continuous innovation and strategic partnerships to overcome obstacles and drive progress in drug discovery.
Follow our website for in-depth articles and industry updates: https://www.pharmanow.live/...2024-08-1626 min
Voices of PharmaRevolutionizing Cell Culture Media, ft. Dr. Yaron Silberberg | #E07-Voices of Pharma | Pharma NowIn the seventh episode of Pharma Now, we sit down with Dr. Yaron Silberberg, Solution Center Director of Ajinomoto CELLiST, to discuss the company's cutting-edge approach to cell culture media development.
Ajinomoto CELLiST specializes in creating customized media solutions tailored to specific cell lines and therapeutic modalities, with a particular focus on gene therapy and biologics production. Dr. Silberberg highlights the company's unique approach, which combines traditional experimentation with advanced AI and machine learning techniques to optimize media composition and enhance productivity.
He also shares insights into Ajinomoto's expansion into India, where they aim to...2024-08-0709 min
Voices of PharmaMr. K Raja Bhanu explains the importance of drugs, presence of India in pharma, startup investments | #E06-Voices of Pharma | Pharma NowIn this interview, Mr. K Raja Bhanu, a distinguished leader in the pharmaceutical industry, shares his remarkable journey from a regulatory officer to the Director General of PharmExcil. With extensive experience and deep insights, Mr. Bhanu discusses the role of PharmExcil in promoting India's pharmaceutical exports and the significant milestones achieved over the years.
He sheds light on the evolution of India's pharma exports from $3.9 billion in 2004 to $27.8 billion in 2024, the importance of trade shows and exhibitions, and the future focus on innovation, biosimilars, and personalized medicines. Mr. Bhanu also highlights government initiatives and support for the sector, emphasizing...2024-08-0313 min
Voices of PharmaDr. Pratima Srivastava elucidates India's future in CRO, Humans vs AI | #E04-Voices of Pharma | Pharma NowJoin us in an enlightening conversation with Dr. Pratima Srivastava, Vice President at Aragen, as she shares her incredible journey in the world of pharmaceutical research and development.
From her early aspirations of becoming a scientist to her current role at one of the largest CROs in the country, Dr. Srivastava offers valuable insights into the challenges and triumphs of a career in R&D.
Discover her thoughts on the evolving role of CROs, the impact of AI and ML in research, and her advice to the younger generation passionate about making a mark in science.
2024-08-0212 min
Voices of PharmaTransforming at team of 10 people to 300, Dr. Sathish shares his inspiring journey with Anthem Biosciences | #E05-Voices of Pharma | Pharma NowIn this insightful interview, Dr. Sathish Sadagopan, Head of R&D at Anthem, shares his fascinating journey from academia to leading one of India's top CROs. Learn about his early passion for biology, his groundbreaking work in virology, and his transition back to India to build a thriving R&D division.
Dr. Sathish discusses the evolving role of CROs, the impact of AI in research, and the future of R&D in India.
Follow our website for in-depth articles and industry updates: https://www.pharmanow.live/
Follow our social media handles:
Fa...2024-08-0213 min
The Morning BriefThe Biggest Indian Pharma Deal of the DecadeMankind Pharma has announced it will buy biotech company BSV for a whopping Rs 13,630 crore. The deal brings together a master of mass market products and an intrinsic innovator in the high entry barrier spaces of the healthcare market. It’s an expensive buy and Mankind has gone for broke, raising equity and debt and stalling other planned purchases. Why is the deal so important and how will it transform Mankind Pharma’s position in the industry? Host Anirban Chowdhury, ET’s pharma expert Vikas Dandekar, Sheetal Sapale from Pharmarack, and Mankind co-founder Rajeev Juneja weigh in. ...2024-07-3021 min
Twisted TruthsGeneric Medicine | The Secret to Affordable Healthcare | Pharma Secrets Exposed | Ep. 39
Dr. Sujit Paul, Group CEO of Zota Healthcare Ltd., debunks the myths of generic medicine, explaining why you should consider using it to save lakhs of rupees and more! 💊❌💸
The full podcast is out.
Joydeep Sen Sujit Paul DavaIndia Generic Pharmacy Zota Healthcare Ltd.
[Future of Medicine, Generic Medicine, Healthcare Revolution, Pharma Secrets, Save Money, Healthcare Secrets, Twisted Truths Talks, Podcast]
Follow Twisted Truths' social media handles:
YouTube: https://www.youtube/@twistedtruthsbydgf
Instagram:https://www.instagram/twistedtruthsbydgf
Facebook:https://www.facebook/twistedtruths
Spotify:https://www.podcasters.spotify.com/po...
For any other queries, email: info@dandgfilms.com
Host & Creative Director...2024-07-2339 min
Twisted TruthsGeneric Medicine | The Secret to Affordable Healthcare | Pharma Secrets Exposed | Ep. 39Dr. Sujit Paul, Group CEO of Zota Healthcare Ltd., debunks the myths of generic medicine, explaining why you should consider using it to save lakhs of rupees and more! 💊❌💸 The full podcast is out. Joydeep Sen Sujit Paul DavaIndia Generic Pharmacy Zota Healthcare Ltd. [Future of Medicine, Generic Medicine, Healthcare Revolution, Pharma Secrets, Save Money, Healthcare Secrets, Twisted Truths Talks, Podcast] Follow Twisted Truths' social media handles: YouTube: https://www.youtube/@twistedtruthsbydgf Instagram:https://www.instagram/twistedtruthsbydgf Facebook:https://www.facebook/twistedtruths Spotify:https://www.podcasters.spotify.com/po... For any other queries, email: info@dandgfilms.com Host & Creative Director: Joydeep...2024-07-2339 min
Weekend Hustlers - The Mayukh ShowEp24 Game of Pills: How Weight-Loss Drugs are Reshaping India's Pharma Market - In BanglaIn a nation where every bite counts and fitness is the new craze, India's battle with weight loss is taking a fascinating turn. With obesity rates soaring, many Indians are turning to a quick fix: weight-loss drugs from abroad. But what happens when a U.S. pharma giant gets early approval for a revolutionary drug in India? This story uncovers the real impact on the pharmaceutical industry, the fitness world, and even your daily life. Stay tuned to discover the unexpected twists and turns of India's weight-loss drug frenzy. Click play to dive into this gripping tale!
2024-07-0706 min
Health WealthHow are medicines and vaccines regulated? | Health Wealth, Ep 45Have you ever wondered how a medicine is tested before it reaches your pill box? And are the words 'phase 2 trials' enough to inspire blind confidence in modern-day vaccines?In this episode, we discover the importance and purpose of clinical research and trials with Dr Sanish Davis, president of the Indian Society for Clinical Research. Having worked on both sides of the fence--in academics and the big pharma industry--Dr Davis takes us behind the scenes of a clinical trial from start to finish.Tune in for an in-depth analysis of India's drug regulatory process, the global...2024-06-0347 min
Moneycontrol PodcastAjanta Pharma, Coal India, Coforge Q4 and more | Market MinutesIn this episode of Market Minutes, Sucheta Anchaliya talks about all the important factors to watch today developments: Ajanta Pharma, Coal India, Coforge Q4 to global market setup. Also catch Avani Bhatt, Senior Vice President- Derivative research at JM financial in the Voice of the Day segment. Market Minutes is a morning podcast that puts the spotlight on hot stocks, keys data points and developing trends2024-05-0307 minInside Forbes IndiaInside Novartis' outsized play in IndiaForbes India's Manu Balachandran talks about Vasant 'Vas' Narasimhan, CEO, Novartis, the youngest amongst his pharma peers at 47, a trained doctor who has come up the ranks from R&D. Balachandran delves into our latest cover story which dissects Novartis' play in India2024-04-1812 min
Insights by Pharma.AeroEp. 11 - Regional Characteristics in Healthcare Logistics (India and Brazil) - Guarulhos International Airport, CSC India, TIACAHave your say – leave a message!Join Frank Van Gelder and his guests in exploring regional and global challenges of healthcare logistics, spotlighting the unique challenges faced by two distinct markets – India and Brazil.Hugo Repolho - Head of Commercial and Strategy Air Cargo at Guarulhos Airport in BrazilTushar Jani - Group Chairman of Cargo Service Centre India Glyn Hughes - Director General, TIACARegional Growth ChallengesIndia's Position as the Global PharmacyCapacity Upliftment and ConnectivityInfrastructure and Challenges in Air CargoSustainability and Environmental ImpactThe Role of ESG in Pharma LogisticsThe Importance of Colla...2024-02-0521 min
The Ranveer Show हिंदीPharma King Rajeev Juneja - How Hard Work Led To "Billions" | Medicines, Condoms & More | TRS हिंदीMankind Pharma's New Launch - https://upakarma.com/
Mankind Pharma को Social Media पे Follow कीजिए :-
YouTube : https://www.youtube.com/channel/UCRnBT-DEKwKLkjIVe37Vu8Q
Instagram : https://www.instagram.com/mankindpharmaltd
Facebook : https://www.facebook.com/MankindPharmaIndia/
Twitter : https://twitter.com/Pharma_Mankind
LinkedIn : https://in.linkedin.com/company/mankind-pharma-ltd
Website : https://www.mankindpharma.com/
राजीव जुनेजा जी को LinkedIn पे Follow कीजिए - https://in.linkedin.com/in/rajeev-juneja-27882a24b
BeerBiceps SkillHouse का Course Join करने के लिए यहाँ CLICK करें : https://bbsh.in/launch-yt
Use my referral code OFF50 to get a 50% Discount on a standard membership subscription. Valid till 15th January 2024 Only.
BeerBiceps SkillHouse को Social Media पर Follow करे :-
YouTube : https://www.youtube.com/channel/UC2-Y36TqZ5MH6N1cWpmsBRQ
Instagram : https://www.instagram.com/beerbiceps_skillhouse
Webs...2024-01-061h 25
Shortcast over CoffeeThe Little Known Shady Face of Indian Pharma with Dinesh ThakurMy guest today is Dinesh Thakur. Dinesh Thakur trained as a chemical engineer before becoming a whistleblower against the pharmaceutical company Ranbaxy. While working at Ranbaxy, he witnessed extensive data fraud and reported this wrongdoing. His actions led Ranbaxy to plead guilty in an American court in 2013 to violating US law. The company paid a $500 million dollar penalty as part of its guilty plea. For his whistleblowing efforts, he received the Joe A. Callaway Award for Civic Courage and the ACFE Cliff Robertson Sentinel Award. Since 2014, he has advocated reforming India's outdated Drugs & Cosmetics Act from 1940. He founded an...2023-11-081h 06
Pharma Marketing Playbook: Data, GenAI, and BeyondThis is the Pharma Marketing Playbook: Data, GenAI, and BeyondWelcome to the epicenter of innovation, where pharma marketing meets Data, GenAI, Social intelligence, Influencer Marketing, and Scientific listening. On this podcast, there is a playbook for every pharma marketing need of yours!Meet your host:Saumya Prakash is an accomplished entrepreneur and tech enthusiast, specializing in AI and IT Software with a keen focus on the pharmaceutical and technology sectors. Holding an MBA from SP Jain Institute of Management and a B.Tech in Computer Science from BITS Pilani, she achieved recognition on the Dean's list at both institutions.2023-10-1301 min
Indian Market StoryInvesting in Pharma Stocks | Pharma Sector Analysis 2023 | E20Expert insights on pharma stocks and get detailed analysis of pharma sector stocks like Sun Pharma, Cipla, Biocon, Mankind Pharma, Divis Lab & Top Pharma Stocks in India Explore the dynamic world of investing in the pharma sector stocks with Mr. Dipan Mehta, a renowned market expert. In this exclusive podcast, he dives deep into the strategies and insights that can help you make informed decisions when it comes to pharma sector companies and pharma stocks. Discover the potential growth opportunities and challenges within the pharma sector, and gain the knowledge you need to navigate this ever-evolving market.• • • To Know More...2023-09-2236 min
From the bookshelves of Forbes IndiaSam Santhosh’s leadership learnings for the first-time Indian entrepreneurThe self-made businessman has worked with several pharma and biotech companies for targeted therapies and innovation through his company MedGenome. He has also incubated and launched many companies leveraging next-generation sequencing and bioinformatics through his incubator SciGenom Labs. He talks to host Divya Shekhar about his book, ‘Sam’s 12 Commandments for the Indian Entrepreneur’, where he draws upon over 35 years of experience to delve deep into the psyche of Indians doing business and shares lessons that will help them succeed. 2023-06-2224 min
Everybody Hates PharmaThe Digital Transformation of Indian Pharma: Insights, Innovations, and CollaborationsIn this episode of the Pharma Sales and Tech podcast, join us for an engaging discussion with Krishnendu Paul, an expert in the Indian pharmaceutical market, as we uncover the fascinating journey of the industry, its digital transformation, and the future prospects of Indian pharma on the global stage. Gain valuable insights into product innovation, marketing strategies, and the potential of digital tools in empowering doctors. Don't miss this insightful episode packed with valuable insights and actionable advice.Key Takeaways:The Indian pharma industry experienced significant changes after the opening of the economy in 1991, leading...2023-05-2631 min
EMJ GOLD: Pharma marketing, medical & moreDriving access to all medicinesThis week on the GOLD podcast, the team is joined by Claudia Martínez, Research Programme Manager, Generics and Diabetes Care, Access to Medicine Foundation, to discuss all things access within the pharmaceutical industry. In this episode, Claudia and Jade explore a range of topics, including the story behind her passion for access to medicine, the industry's progress in making medicines more widely available in low- and middle-income countries and the Foundation's latest focus on driving access to generic drugs. If you’re interested in learning more about the topic areas discussed in this episode, check out the...2023-03-1425 min
AIF & PMS Experts India PodcastHow's Indian Pharma Sector Shaping Up? Is This The Right Time To Invest in Pharma?Topic :- Hows Indian Pharma Sector Shaping Up? Is This The Right Time To Invest in Pharma?
Speaker : Mr Aditya Khemka - Fund Manager - InCred Asset Management
Host :- Mr Vikas Agrawal - AIF & PMS Experts India Pvt. Ltd.
AIF & PMS Experts India Pvt. Ltd is one of the leading digital online platforms for AIF & PMS in India, offering bespoke private wealth solutions and strategies to our investors. We have expertise in Alternative Investments Fund and Portfolio Management Services. We believe the opportunities here are immense. We are committed...2023-02-1449 min
THE ONE'S CHANGING THE WORLD -PODCASTBIO-HACKERS VS PHARMA INDUSTRY- JO ZAYNER -CEO : THE ODIN#biotechnology #biohacking #genetics #toctw #podcast Dr. Jo Zayner is a global leader in the BioHacker movement, constantly pushing the boundaries of Science outside traditional environments. They started BioHacking during their Ph.D. in Molecular Biophysics at the University of Chicago, creating The Chromochord in their apartment, the world’s first musical instrument that uses engineered protein nanotechnology. After their Ph.D., Jo received a prestigious fellowship to work with NASA's Synthetic Biology program, engineering bacteria to help terraform Mars. Now they are the Founder and CEO of The ODIN. Jo has a number of Scientific publications and awards for their...2023-01-2349 min
THE ONE'S CHANGING THE WORLD -PODCASTARTIFICIAL INTELLIGENCE & BIG DATA FOR HEALTHCARE- DR SHAMEER KHADER-EXEC DIR: SANOFI#healthcare #artificialintelligence #bigdata #ai #toctw #podcast
Dr. Shameer Khader is an Artificial Intelligence leader in drug discovery and advanced healthcare, with over 20 years of experience in the industry. His expertise lies in bioinformatics, big data, and biomedical data science, and he has strong domain experience across multiple verticals including pharma, biotech, med-tech, digital health, precision medicine, genomics, and drug development. Dr. Khader has previously worked at companies such as AstraZeneca, Philips, and Mayo Clinic, and is currently the Executive Director and Global Head of Data Science at Sanofi. He has been recognized as one of the "100 Leading P...2023-01-1649 min
THE ONE'S CHANGING THE WORLD -PODCASTARTIFICIAL INTELLIGENCE & BIG DATA FOR HEALTHCARE- DR SHAMEER KHADER-EXEC DIR: SANOFI#healthcare #artificialintelligence #bigdata #ai #toctw #podcast
Dr. Shameer Khader is an Artificial Intelligence leader in drug discovery and advanced healthcare, with over 20 years of experience in the industry. His expertise lies in bioinformatics, big data, and biomedical data science, and he has strong domain experience across multiple verticals including pharma, biotech, med-tech, digital health, precision medicine, genomics, and drug development. Dr. Khader has previously worked at companies such as AstraZeneca, Philips, and Mayo Clinic, and is currently the Executive Director and Global Head of Data Science at Sanofi. He has been recognized as one of the "100 Leading P...2023-01-1649 min
THE ONE'S CHANGING THE WORLD -PODCASTREVERSING AGE WITH PARTIAL CELLULAR RE-PROGRAMMING- YURI DEIGIN- CO-FOUNDER: YOUTH BIO THERAPEUTICS#agereversal #technology #podcast #genetics #science
REVERSING AGE WITH PARTIAL CELLULAR RE-PROGRAMMING Yuri Deigin is a biotech entrepreneur with a focus on early-stage translation of scientific breakthroughs into therapies. He has over a decade of drug discovery and development experience, and a track record of out-licensing products to Big Pharma. Yuri has previously led several early-stage pharmaceutical startups, including one developing an Alzheimer's Disease therapeutic, and another startup developing small-molecule neuroprotectors for Alzheimer's, Parkinson's, and a rare pediatric disease.
Additionally, Yuri has been a vocal evangelist of epigenetic rejuvenation by partial reprogramming with Yamanaka factors since 2017. Y...2022-12-1245 min
CPhI Podcast SeriesThe importance of Pharma 4.0 to innovation leads in IndiaIn this latest episode from the CPHI Podcast Series, Digital Editor Lucy Chard speaks to Sanjay Sharma, Global Head of Manufacturing, from Dr Reddy’s. Sanjay has over 26 years of experience in roles encompassing sales, the supply chain, and technical operations.Pharma 4.0 is the upgrading of the pharma industry to a more digitalised state, including automation of processes and greater system integration. This has a wealth of advantages, such as leading to greater compliance and quality control in the manufacturing process. Pharma 4.0 also leads to increasing the sustainability of many aspects of the pharmaceutical chain. Dr Reddy’s is...2022-12-0116 minFrom the bookshelves of Forbes IndiaCan we trust India's drug regulator? Dinesh Thakur and Prashant Reddy weigh inHow safe are medicines made in India? Four cough and cold syrups made in India have allegedly caused the death of 66 children in the African nation of Gambia, which the Indian drug regulator is currently investigating. The syrups contained diethylene glycol (DEG) and ethylene glycol, which can be fatal for humans who consume it. India has had a record of at least five major events of poisoning by DEG in the past. In today's episode, Dinesh Thakur and Prashant Reddy, authors of The Truth Pill (published by Simon & Schuster India), speak with Divya Shekhar about the problem with drug regulat...2022-10-2023 min
The Career Rx Podcast for Doctors#104 - Getting a job in pharma without US license or clinical practice - with Dr. Rohan SopariwalaInterested in pharmaceutical career options without a US license? Whether you’re an international medical graduate (IMG) or you have not completed US board certification or residency training, this episode is for you.In this episode of The Career Rx we’ll discuss:Dr. Rohan Sopariwala’s strategies for getting started in US pharma as an IMGHow to compensate for lack of experience so you sound experienced in interviews What prospective companies are really looking for in physician job candidatesToday’s episode i...2022-10-0422 min
Pride and PrejudiceHousing discrimination: Finding a safe place to call home changes queer livesIt has been 3 years since the Supreme Court read down section 377 and 75 years since Indian independence. So, let’s see how free queer people are when it comes to finding a home. In this episode of Pride and Prejudice, our reporter Suryatapa Mukherjee spoke to Raju Behara, Ritushree Panigrahi and Kushal Roy. They speak about their struggles with finding a safe accommodation where they can truly be themselves, and also the transformational joy that finding a home can bring. Raju is a non-binary person and they write for a Pharma company. They also work as a peer su...2022-09-1632 min
Forbes India - Tech ConversationsDuncan Emerton at Pharma Intelligence on the biosimilars opportunity propelling Biocon’s $3.3 bln Viatris dealOur guest today is Duncan Emerton, executive director, custom intelligence and analytics, at Informa Pharma Intelligence. Informa is a UK based business intelligence provider and consultancy. In this episode, Duncan explains some of the basics of why biosimilars are a huge opportunity and how Biocon’s deal to purchase the biosimilars unit of its long-term partner Viatris ticks several boxes for the Bangalore company.
(00:40) Introduction to The Daily Tech Conversation
(00:52) Our guest today — Duncan Emerton, executive director, custom intelligence and analytics, Informa Pharma Intelligence
(01:42) A snapshot of Duncan’s work and expertise
(03:01) A layman's defini...2022-04-0633 min
The Medicine BoxThe Medicine Box: Torrent Pharma eyes double digital domestic growth, cardiology key focus, says ED Aman MehtaTorrent, an over 60-year-old Indian pharma company, the flagship company of the Torrent Group, is most recognised for its strong domestic focus. It is the eighth largest player in India, with around 40 percent of its revenues from the domestic market.
It has strengthened its presence with acquisitions in the past 10 years such as buying Elder Pharma’s domestic business in 2014 for Rs 2000 crore and Unichem’s domestic business in 2017 for Rs 3600 crore. Domestic market brands include Shelcal, Unienzyme and Nebicard.
In this edition of The Medicine Box Podcast, CNBC-TV18’s Ekta Batra gets in conversation with Torren...2022-03-2921 min
MoveConversationsIndian Pharma A SWOT Analysis; Discussions with Udayan Sengupta - Part 2TradeStuff by MoVeConversations, a series of talks on trade and related topics, presents a three-part discussion with Mr. Udayan Sengupta, Director, Sourav Chemicals Limited (SCL India). SCL manufactures of a wide range of Active Pharmaceutical Ingredients for global customers.We talk to Udayan about the Strengths, Weaknesses, Opportunities and Threats that Indian pharmaceutical industry faces.While India supplies over 50% of global demand for vaccines, and over 80% of the drugs to fight AIDS, did you know that Poland has 16 Technology Parks for the pharma industry just between Warsaw and Krakow? Over 600 companies, 10 universities and institutes are...2022-01-1731 min
MoveConversationsIndian Pharma A SWOT Analysis; Discussions with Udayan Sengupta - Part 1TradeStuff by MoVeConversations, a series of talks on trade and related topics, presents a three-part discussion with Mr. Udayan Sengupta, Director, Sourav Chemicals Limited (SCL India). SCL manufactures of a wide range of Active Pharmaceutical Ingredients for global customers.We talk to Udayan about the Strengths, Weaknesses, Opportunities and Threats that Indian pharmaceutical industry faces.Did you know?- India supplies over 80% of the antiretroviral drugs used globally to combat AIDS- India supplies over 50% of global demand for vaccines- India supplies 40% of generic demand in the US2022-01-1719 min
Pharma Franchisee IndiaTips to Select Reliable PCD Pharma Franchise Company in IndiaHere are the tips which you must consider in mind while selecting own Pharma Franchise Company for PCD pharma franchise business on the monopoly basis. https://bit.ly/3FMY8Du2021-12-3102 min
Inside Forbes IndiaForbes India Rich List: Key numbers you should knowThe annual Forbes India Rich List 2021 issue is on stands now, and Ruchika Shah, who dissects the rich list data every year to bring you insights and trends from the 100 richest Indians' net worth, takes you through the key numbers that you must know. Like, which sector surprisingly didn't do too well this year; and which is the up & coming sector that could go neck and neck with IT and pharma by the next decade. Who's the richest (no surprises there!), and who are the youngest billionaires (one of them is a woman), and lots of other trivia2021-11-1009 min
Pharma Franchisee IndiaPCD Pharma Franchise Business Opportunity in IndiaPlanning to start own PCD pharma franchise business in India? Here we have mentioned some important point which you must consider in mind while selecting best Pharma PCD Company for the pharma franchise business. https://www.atoallinks.com/2021/pcd-pharma-franchise-business-opportunity-in-india/2021-09-2402 min
Pharma Franchisee IndiaWhat is PCD Franchise and scope of PCD Pharma Franchise Business?If you are new in the pharma franchise business then check out our recent published podcast to know more about the PCD pharma franchise concept and scope of pharma pcd business in India. https://bit.ly/3DoCODu2021-08-2803 min
IDEA Collider: Innovation & Asymmetric Learning in PharmaIDEA Collider | Kabir NathKabir Nath is President & CEO, Otsuka North America Pharmaceutical Business Throughout his career, Kabir has built bridges between cultures. His work has taken him across the globe, spanning 3 continents and multiple countries. Kabir has lived and worked in the United Kingdom, France, Spain, India, Singapore, China, and the United States. He has consistently inspired those around him to go beyond cultural and linguistic differences to bring new concepts and ideas to life, forging stronger partnerships rooted in diverse experiences. For Kabir, leadership is not about having all the answers, rather, it is about creating an environment where O...2021-08-2652 min
Pharma Franchisee IndiaGet the Best Derma PCD Franchise Company for Franchise BusinessLooking for the best derma pcd companies for the pcd franchise business? If yes, Checkout the podcast to know about the tricks and tips for selecting the right Derma franchise company. https://bit.ly/2VRbPj22021-08-1305 min
DocSpeaks - Hypertension WellnessHow Salt can impact your Blood Pressure and CKD | Dr. Rajesh AgrawalHypertension or high blood pressure is the most important risk factor for chronic disease burden in India. Studies from various parts of India have reported prevalence as high as 30% in the country. This means that every third person in India suffers from hypertension.
In order to bridge this gap, Ajanta Pharma has taken the initiative of arranging this podcast with the expert of hypertension management, Dr. Rajesh Agrawal a distinguished Diabetologist from Indore M.P.2021-07-2705 min
Pharma Franchisee IndiaTips to Choose the Best Derma PCD Pharma Franchise CompanyHere we have discussed about the tips and tricks which must consider in mind while selecting the top and best Derma PCD Pharma Franchise Company for the franchise business. https://bit.ly/3B8KZmm2021-07-1604 min
Pharma Franchisee IndiaKnow Advantage and Profit Investing in Derma PCD FranchiseIf you are the new comer in the Indian pharmaceuticals industry let’s have a look on the published audio post to know more about the advantage and profit investing in Derma PCD Franchise business in India. https://bit.ly/2Vunm7q2021-07-1004 min
Pharma Franchisee IndiaSeveral Advantages of Owning a Pharma Company FranchiseIf you are planning to invest your hard earned money in the pharmaceuticals business, Here we have discussed about the several benefits of starting own PCD pharma franchise business. Check out here: https://bit.ly/3qhPo162021-06-2303 min
Shadow Warrior by Rajeev SrinivasanEp. 34: What could India have done when a Black Swan event hit?A version of this article has been published by rediff.com at https://www.rediff.com/news/column/india-blundered-along-like-others-did/20210623.htmThere is a loud chorus of voices blaming India for somehow messing up its response to the massive wave of Wuhan virus (Covid-19) infections that have devastated the country. Many articles and editorials have come out in both the Indian media and western media suggesting that the Government of India was negligent, indifferent, or both; in effect that it criminally abdicated its responsibility to the people of India. It is normal to expect these cavils f...2021-06-1212 min
Exim Talk Show By Digital EximEpisode 103 | Pharma Export Is the BEST Export From IndiaIndia ranks No 1 in exporting Pharma products in the year 2020Join India, expand its Exporting Empire!Listen to our Podcast to know all about Pharma ExportCall us now to claim Advanced Export TrainingYou can share your name and number in the commentsCall 9898724798 | www.digitalexim.com#livepodcast #pharmaexport #pharmaexportfromindia #indiaexports #worldimports #eximpodcast #eximtradewithdigitalexim #eximpodcast #podcast #exportfromindia #indianexporters #exporters #indiaexports #exportimport #exporttraining #digitalexim #exportcourse #globlbusiness #advancedtraining #digitaleximexperts #internationalbusiness #eximtrade--- Send in a voice message: https://anchor.fm/digital-exim/message2021-06-1102 min
Career CheckpointAnshuman Gupta: Career arc of a top pharma analystIn this episode, I speak with Anshuman Gupta. Anshuman works with Investec India and as per Asiamoney Brokers Poll, he is the No. 1 Healthcare Analyst in the India region and No. 2 globally. I took this opportunity to get Anshuman to explain to me the basics of the Indian pharma space. We covered India’s contribution to the world pharma industry, regulations, generics and of course, the COVID vaccinations. I also found out about Anshuman’s career arc - from being a chemical Engineer to the top pharma analyst that he is today and what he would have done had he n...2021-06-0553 minPharma Franchisee IndiaPopularization of PCD Pharma Franchise in IndiaAre you planning to invest your hard earned money into the pcd pharma franchise business then get in touch with Pharma Franchisee India? We are the fastest growing complete online b2b pharmaceuticals marketplace of pharma products. https://bit.ly/2Qgwt9u2021-04-2004 min
Conversations On IndiaThe Quad, Pharma and medical devices sector, Protecting Indian Telecom (Ep 15)Discussing the following topics : 1]The Quad. 2]Pharma and medical devices sector. 3]Protecting Indian Telecom. 4]Promoting Native languages. @siddharthsigroha with quote of the day:"Every two weeks, A language dies"2021-04-0759 min
Capital IdeasCapital Ideas, with Borosil's Shreevar Kheruka: Changing with the timesStarted in 1962, Borosil now has two listed firms: Borosil Ltd, which sells kitchen appliances and cookware, lab-wares and pharma packaging and the solar glass manufacturing renewables business. A fortnight back Borosil Renewables raised Rs 200 crore to double its capacity, and the group recently underwent restructuring earlier this year to chart independent growth for both the businesses. The company's managing director Shreevar Kheruka talks about the impact of Covid-19 on business, the ways the group is seeking to cut bad costs, how work from home is here to stay and what they did to make their balance sheet stronger this y...2020-12-2826 minInside Forbes IndiaWhy is Dr Reddy's Laboratories bringing the Russian vaccine to India?While the Russian Sputnik V vaccine follows a similar path as the Oxford-Astrazeneca vaccine of being based on the human adenovirus, a common cold virus fused with the spike protein of Sars-Cov-2 to stimulate an immune response, its approval and registration without the crucial Phase III trial and consequent tie-up with Dr Reddy's Laboratories has made headlines. Manu Balachandran, author of this fortnight's cover story delves into GV Prasad and Dr Reddy's long-standing relationship with Russia, the country's apparent transparency with the pharma company, and why it bet on the controversial vaccine2020-10-1212 min
TeenpreneursEp 11: The 18-yr-old pharma wonderkid that Ratan Tata has invested inAs a teenager, Arjun Deshpande was surprised to find that about 60 percent of Indians cannot procure medicines they need, because of high costs and other barriers. After research on the indudstry, he founded Generic Aadhar at 16, a B2B2C venture that sources generics directly from manufacturers, retailing them at a fraction of the cost. Now, it has expanded across India, from Jammu to Nagaland. Hear more about how Deshpande juggles education and his business, and future plans for Generic Aadhar, on this episode.
Read more about it here: https://www.forbesindia.com/article/special/meet-the-17...2020-09-2222 minFrom the bookshelves of Forbes IndiaEp. 30 Katherine Eban: Ranbaxy and the dark side of Indian pharmaNew York-based journalist Katherine Eban uncovered a web of lies when investigating the rot within the Indian pharmaceutical industry, with help from whistleblowers. On this episode, she talks about her book 'Bottle of Lies', being followed and spied on while reporting in China, and unveiling the mess at Ranbaxy, which had been fabricating their test results, endangering millions of patients2020-09-1630 min
The First Indian Pharma PodcastA conversation with V K Sharma(CEO-Dezin consulting) Part 1In this podcast we discuss about the journey and mistakes in the beginning of career, and also many success stories of pharma Brands in India.2020-08-1715 minFrom the bookshelves of Forbes IndiaEp 21. Gerald Posner: Cannabis, heroin and the poison at pharma companiesAward-winning journalist and bestselling author joins us on this week's episode to discuss his book 'Pharma', tracing the heroes and villains of the pharmaceutical industry—stories of greed, corruption, drugs and reckless profiteering—especially relevant in the Covid-19 world2020-07-1629 min
Pro Pharma TalksWhat Happened to Lowering the Cost of Drugs?1. Goal: Lower drug cost so that they are affordable to patients
a. US Rate of Inflation (2017-2019) = 2.14% to 1.8%
b. CPI = 2.0%
c. CPI (health care) = 2.8% (2019)
2. Drug Cost Transparency
a. Transparency = cost
b. CA SB17: WAC >= $40 with 16% inflation in prior year, or 32% inflation in last 2 years
3. How do they differ? Are they effective? Pros/Cons
a. White House Plan
b. Congressional Action
c. Congress – Democratic Plan
4. State Plans – What are they trying to do? Pros/Cons
a. California
b. New York
5. Discoun...2020-07-0240 min
Business IndiaHuge scope for Indian pharma as FDA eases drug scrutiny over shortage in USHuge scope for Indian pharma as FDA eases drug scrutiny over shortage in US2020-05-1803 minBusiness IndiaPharma traders protest govt's move to add e-pharmacy links to Aarogya SetuPharma traders protest govt's move to add e-pharmacy links to Aarogya Setu2020-05-1801 minBusiness IndiaAlembic Pharma hits new high, surges 45% in 4 weeks on strong Q4 resultsAlembic Pharma hits new high, surges 45% in 4 weeks on strong Q4 results2020-05-1503 minBusiness IndiaStocks to watch: Biocon, Cipla, Aurobindo Pharma, Tata Group stocks, NocilStocks to watch: Biocon, Cipla, Aurobindo Pharma, Tata Group stocks, Nocil2020-05-1503 minBusiness IndiaAntibiotic sales drive domestic pharma mkt down 11.2% in lockdown-hit AprilAntibiotic sales drive domestic pharma mkt down 11.2% in lockdown-hit April2020-05-1304 minBusiness IndiaLockdown serves domestic pharma the bitter pill: April growth slipsLockdown serves domestic pharma the bitter pill: April growth slips2020-05-1305 min
Investec IndiaCOVID19 impact on the drug manufacturing in IndiaInvestec India hosted Mr Sanjeev Jain (Promoter, Akums Drugs & Pharma – Largest Branded Formulation Contract Manufacturer for Domestic Market) . Mr Jain spoke about the various trends like the demand for GP type medicines like paracetamol and crocin falling amid the COVID19 crisis, whereas diabetic, cardiac and CNS medicines seeing a regular demand, the growth of generic-generic medicines in India and behavioural changes among the patients who are scared to go to doctors, and docs themselves are grappling about opening their clinic with proper protocols.
Mr. Jain is the co-founder & the director of Akums Drugs & Pharma Ltd and has 25+ years of...2020-05-0414 min
Investec IndiaCOVID19 Impact - FDA and other Regulatory approvals for Indian pharmaInvestec India hosted K Anand FDA and Regulatory Consultant to understand the developments on the FDA and other Regulatory approvals during the COVID19 crisis. Mr Anand explained that the Indian Pharma industry caught the attention of USA and Europe due to the proposed coronavirus medicines - HCQ and Erythromycin - requirements as these countries don’t manufacture these products. Barring coronavirus treatments, in other areas too, India has been in the spotlight of international communities. Mr Anand believes that the Indian pharma has a huge potential to rise to the occasion for supplying products to the international and domestic markets in...2020-05-0413 min
Investec IndiaCOVID-19 Impact on the Indian Pharma SectorOn the back of the global pandemic as well as the Big Outperformance for the Indian Pharma sector over benchmark indices in recent times, the Investec Pharma team hosted a 7 Industry Experts Series over 5 Days in April. US, India & API businesses were central to discussions.
The series, which generated an overwhelming response among global investors, gave a very good perspective and a solid on-the-ground / transparent view across the pharma value chain during the COVID crises; not just the current situation but it also set investor expectations for the near future, which appears quite uncertain.
After a cautious approach...2020-05-0310 min
Investec IndiaPharma Expert Series - Sakti ChakrabortySakti Chakraborty (Ex - Lupin India Business Head) speaks to Anshuman Gupta, pharma analyst at Investec India about the trends that will be seen in the pharma sector, the challenges in the demand - supply for medicines across India and what changes in behaviour the industry will notice due to the COVID19 protocols.
A veteran in the Pharma sector, Mr. Chakraborty has led a successful and a greatly accomplished career spanning more than four decades with major pharma giants like Aristo, Alkem, Wockhardt & Lupin. Before stepping out to start his own venture (Ergos Life Sciences), Mr. Sakti was the...2020-05-0153 min
OptionablesImpact of Coronavirus on Pharma SectorIndia follows a model wherein raw ingredients are imported from China and the finished drugs are sold globally. Due to the spread of the coronavirus, and the decrease in imports from China, the exports of pharma in India are affected.2020-04-1903 minIDEA Collider: Innovation & Asymmetric Learning in PharmaIDEA Collider | In conversation with Nooman Haque00:20 Introduction: what does Silicon Valley Bank's Life Sciences and Healthcare group do?01:00 Nooman's background01:30 How does SVB fit into the innovation ecosystem?02:00 Lending to companies who don't have products02:15 How does innovation happen: the myth of the lone inventor; the value of connections03:15 Parallels to non-pharma innovation models and ecosystems03:45: Innovation as the deployment into a market for the betterment of people and society04:10: Invention, innovation and diffusion of the innovation06:00 How does pharma compare?06:15 How do the incentives influence R...2019-11-061h 04
The Medicine BoxWhat's trending in pharma & healthcare spaceIn this episode of The Medicine Box, Ekta Batra talks to Sujay Shetty of PwC who leads Pharmaceutical & Life Sciences segment at PWC India and has over 20 years of experience in the pharma and medical devices industry in India, the UK and South East Asia.
#TheMedicineBox on CNBCTV18.com aims to give you an insight on all things pharma and health – from discussing trends in the industry to key issues in health with all the relevant experts. In this series, Batra talks to Shetty about the emerging trends in the pharma and healthcare space such as cost containment, M&A oppo...2019-08-1624 min
Inside Forbes IndiaForbes India Cover Story # 131: Behind Lupins shopping spreeThe pharma major has recently been in serious acquisition mode as it believes inorganic growth will be the driver for its 2018 revenue targets of 5 billion USD. Podcast produced in association with theindicast.com.2016-01-1609 min